People whose biological mothers had diabetes during pregnancy are more likely to develop MS as adults, according to a study ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window "Medical ...

Large Norwegian registry data links birth size and maternal diabetes with higher multiple sclerosis risk, suggesting prenatal ...

People with multiple sclerosis (MS) face a significantly higher risk of perinatal mental illness compared to those with other chronic conditions, according to a new study analyzing over 890,000 births ...

PHOENIX — Two new datasets support the use of potent disease-modifying therapies (DMTs) during pregnancy in women with active multiple sclerosis (MS), reinforcing a growing shift toward treatment when ...

New data on the use of natalizumab (Tysabri, Biogen) during pregnancy in women with multiple sclerosis (MS) have shown that continued use of the drug is associated with a lower risk of relapses during ...

Pre-pregnancy and pregnancy planning for women with MS can lead to treatment changes that may affect risk of relapse. Combining preconception, gestation, and postpartum periods, pregnancy raised ...

Pregnancy seems to increase the risk of mental illness among women with multiple sclerosis. Pregnant MS patients have a higher risk of mental illness during gestation and in the first years after they ...

Many women are diagnosed with multiple sclerosis (MS) at an age when they are considering starting a family. What does the disease and its medication mean for the child? To answer this question, a ...

"Medical Journeys" is a set of clinical resources reviewed by doctors, meant for physicians and other healthcare professionals as well as the patients they serve. Each episode of this journey through ...

Many women with multiple sclerosis remained untreated before conception, during pregnancy, and postpartum, though preconception and postpartum ocrelizumab use increased between 2019 and 2023. Nearly ...

Even women with more severe MS cases are less likely than men to get critical treatments, a new study finds. Women under age 40 with multiple sclerosis are 8 percent less likely than men to receive ...